Current approaches to the therapy of fibrotic diseases.
Cancer Research Department, Zeneca Pharmaceuticals, Macclesfield, Cheshire, U.K.
T J
TJ
Franklin
D003094:Collagen / Q000096:biosynthesis; D016207:Cytokines / Q000037:antagonists & inhibitors*; D004719:Endomyocardial Fibrosis / Q000628:therapy; D005355:Fibrosis / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy; D011393:Procollagen-Proline Dioxygenase / Q000037:antagonists & inhibitors*; D008249:Protein-Lysine 6-Oxidase / Q000037:antagonists & inhibitors*; D011658:Pulmonary Fibrosis / Q000628:therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D015398:Signal Transduction
D016207:Cytokines; D003094:Collagen; D011393:Procollagen-Proline Dioxygenase; D008249:Protein-Lysine 6-Oxidase; D020794:Receptor Protein-Tyrosine Kinases